
|Articles|June 26, 2008
HIV drug Aptivus gains new indication approval for kids
Boehringer Ingelheim's Aptivus can now be used to treat HIV-infected pediatric patients.
Advertisement
Pediatric patients between two and 18 years of age who are infected with HIV have a new treatment available to them. It’s Boehringer Ingelheim Pharmaceuticals’
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Updated COVID-19 Vaccines Effectively Protect Against Symptomatic Infection
2
Serotype 4 IPD Threat for Young Adults, Unvaccinated Men
3
Pharmacists Need Legal, Training Support to Advance Vaccination
4
Functional Somatic Disorder Doesn’t Explain Quality of Life in Long COVID
5
























